secwatch.observer — SEC 8-K summary
======================================

Issuer:     Septerna, Inc. (SEPN)
CIK:        0001984086
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001193125-26-007772
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Septerna appoints Mark A. Wilson as Chief Legal Officer, effective January 8, 2026
--------------------------------------------------------------------------------

- Mark A. Wilson joins from Nektar Therapeutics, where he was SVP and Chief Legal Officer.
- He has over 25 years of experience in IP, corporate legal, and strategic collaborations.
- Wilson will oversee legal, IP strategy, and governance for Septerna's GPCR drug discovery pipeline.
- He previously led global collaborations and patent strategy at Nektar.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1984086/000119312526007772/0001193125-26-007772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1984086/000119312526007772/d40604d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-007772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer